135 related articles for article (PubMed ID: 36201240)
1. Nabilone Impairs Spatial and Verbal Working Memory in Healthy Volunteers.
Kassim FM; Tod S; Rodger J; Hood SD; Lee JWY; Albrecht MA; Martin-Iverson MT
Cannabis Cannabinoid Res; 2024 Feb; 9(1):199-211. PubMed ID: 36201240
[No Abstract] [Full Text] [Related]
2. The effects of caffeine and d-amphetamine on spatial span task in healthy participants.
Kassim FM; Lim JHM; Slawik SV; Gaus K; Peters B; Lee JWY; Hepple EK; Rodger J; Albrecht MA; Martin-Iverson MT
PLoS One; 2023; 18(7):e0287538. PubMed ID: 37440493
[TBL] [Abstract][Full Text] [Related]
3. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600
[TBL] [Abstract][Full Text] [Related]
4. Acute memory and psychotomimetic effects of cannabis and tobacco both 'joint' and individually: a placebo-controlled trial.
Hindocha C; Freeman TP; Xia JX; Shaban NDC; Curran HV
Psychol Med; 2017 Nov; 47(15):2708-2719. PubMed ID: 28558859
[TBL] [Abstract][Full Text] [Related]
5. The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial.
Englund A; Atakan Z; Kralj A; Tunstall N; Murray R; Morrison P
J Psychopharmacol; 2016 Feb; 30(2):140-51. PubMed ID: 26577065
[TBL] [Abstract][Full Text] [Related]
6. Acute separate and combined effects of cannabinoid and nicotinic receptor agonists on MMN-indexed auditory deviance detection in healthy humans.
de la Salle S; Inyang L; Impey D; Smith D; Choueiry J; Nelson R; Heera J; Baddeley A; Ilivitsky V; Knott V
Pharmacol Biochem Behav; 2019 Sep; 184():172739. PubMed ID: 31283908
[TBL] [Abstract][Full Text] [Related]
7. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study.
Mathai DS; Holst M; Rodgman C; Haile CN; Keller J; Hussain MZ; Kosten TR; Newton TF; Verrico CD
J Neuropsychiatry Clin Neurosci; 2018; 30(1):66-76. PubMed ID: 28641496
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids for fibromyalgia.
Walitt B; Klose P; Fitzcharles MA; Phillips T; Häuser W
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011694. PubMed ID: 27428009
[TBL] [Abstract][Full Text] [Related]
9. Developing a phone-based measure of impairment after acute oral ∆
Pabon E; de Wit H
J Psychopharmacol; 2019 Sep; 33(9):1160-1169. PubMed ID: 31407943
[TBL] [Abstract][Full Text] [Related]
10. The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species.
Borgan F; Beck K; Butler E; McCutcheon R; Veronese M; Vernon A; Howes OD
Psychopharmacology (Berl); 2019 Nov; 236(11):3257-3270. PubMed ID: 31165913
[TBL] [Abstract][Full Text] [Related]
11. Does variation in trait schizotypy and frequency of cannabis use influence the acute subjective, cognitive and psychotomimetic effects of delta-9-tetrahydrocannabinol? A mega-analysis.
Freeman AM; Mokrysz C; Hindocha C; Lawn W; Morgan CJ; Freeman TP; Saunders R; Curran HV
J Psychopharmacol; 2021 Jul; 35(7):804-813. PubMed ID: 33427016
[TBL] [Abstract][Full Text] [Related]
12. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K
Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826
[TBL] [Abstract][Full Text] [Related]
13. Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study.
Hill KP; Palastro MD; Gruber SA; Fitzmaurice GM; Greenfield SF; Lukas SE; Weiss RD
Am J Addict; 2017 Dec; 26(8):795-801. PubMed ID: 28921814
[TBL] [Abstract][Full Text] [Related]
14. Δ
Adam KCS; Doss MK; Pabon E; Vogel EK; de Wit H
Neuropsychopharmacology; 2020 Oct; 45(11):1807-1816. PubMed ID: 32386395
[TBL] [Abstract][Full Text] [Related]
15. Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial.
Wissel J; Haydn T; Müller J; Brenneis C; Berger T; Poewe W; Schelosky LD
J Neurol; 2006 Oct; 253(10):1337-41. PubMed ID: 16988792
[TBL] [Abstract][Full Text] [Related]
16. Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information.
Ranganathan M; Radhakrishnan R; Addy PH; Schnakenberg-Martin AM; Williams AH; Carbuto M; Elander J; Pittman B; Andrew Sewell R; Skosnik PD; D'Souza DC
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):176-183. PubMed ID: 28642081
[TBL] [Abstract][Full Text] [Related]
17. Verbal as well as spatial working memory predicts visuospatial processing in male schizophrenia patients.
Silver H; Goodman C
Schizophr Res; 2008 Apr; 101(1-3):210-7. PubMed ID: 18294818
[TBL] [Abstract][Full Text] [Related]
18. A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study.
Koychev I; McMullen K; Lees J; Dadhiwala R; Grayson L; Perry C; Schmechtig A; Walters J; Craig KJ; Dawson GR; Dourish CT; Ettinger U; Wilkinson L; Williams S; Deakin JF; Barkus E
Eur Neuropsychopharmacol; 2012 Jul; 22(7):469-81. PubMed ID: 22137565
[TBL] [Abstract][Full Text] [Related]
19. The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment.
Lawn W; Trinci K; Mokrysz C; Borissova A; Ofori S; Petrilli K; Bloomfield M; Haniff ZR; Hall D; Fernandez-Vinson N; Wang S; Englund A; Chesney E; Wall MB; Freeman TP; Curran HV
Addiction; 2023 Jul; 118(7):1282-1294. PubMed ID: 36750134
[TBL] [Abstract][Full Text] [Related]
20. Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.
Bedi G; Cooper ZD; Haney M
Addict Biol; 2013 Sep; 18(5):872-81. PubMed ID: 22260337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
